Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Primary Immune Deficiency Disorder: early-phase trial registry
5 of 6 indexed Primary Immune Deficiency Disorder trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 5 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Primary Immune Deficiency Disorder: 6 US clinical trials tracked, 5 recruiting.
Primary Immune Deficiency Disorder is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most active sponsor is New York Medical College, running 4 of these trials.
Enrollment posture brief
Registry condition primary-immune-deficiency-disorder
OPEN 5 | RECR 83% | LATE 0 | EARLY 6 | RANK #2866 | SPON 4
Volume-matched condition peers
Nearest open-share peer: Alcoholic Hepatitis (83% recruiting · 6 trials)
Primary Immune Deficiency Disorder lists 5 open slots (83% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Primary Immune Deficiency Disorder on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Primary Immune Deficiency Disorder is recruiting above its size-band peers.
5 of 6 indexed trials (83.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Primary Immune Deficiency Disorder research.
New York Medical College accounts for 4 of 6 trials (66.7%). 3 distinct sponsors appear on at least one study for this condition label.
-
Most Primary Immune Deficiency Disorder trials plan to enrol fewer than 100 people.
Median target enrolment is 27 among the 6 trials that report a genuine target (sentinel values excluded). 5 of those (83.3%) plan for fewer than 100 participants.
-
Primary Immune Deficiency Disorder research is mostly interventional.
6 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)
New York Medical College
NCT04197596
Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
NCT04232085
Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)
New York Medical College
NCT03266640
EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
New York Medical College
NCT03266653
Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection
New York Medical College
NCT03266627
Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant
Bellicum Pharmaceuticals
NCT03301168
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Primary Immune Deficiency Disorder records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Primary Immune Deficiency Disorder trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Primary Immune Deficiency Disorder page
6 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Primary Immune Deficiency Disorder trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- New York Medical College sponsors the most Primary Immune Deficiency Disorder trials on record, review their full trial history before evaluating a specific study. See New York Medical College's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Primary Immune Deficiency Disorder condition card totals 6 registered trials; most-linked intervention cytotoxic t-lymphocytes; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.